SG11201407924RA - METHOD OF TREATING <i>SCEDOSPORIUM SPP</i>. INFECTION - Google Patents
METHOD OF TREATING <i>SCEDOSPORIUM SPP</i>. INFECTIONInfo
- Publication number
- SG11201407924RA SG11201407924RA SG11201407924RA SG11201407924RA SG11201407924RA SG 11201407924R A SG11201407924R A SG 11201407924RA SG 11201407924R A SG11201407924R A SG 11201407924RA SG 11201407924R A SG11201407924R A SG 11201407924RA SG 11201407924R A SG11201407924R A SG 11201407924RA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- infection
- new south
- south wales
- scedosporium spp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 5 December 2013 (05.12.2013) WIPOIPCT (10) International Publication Number WO 2013/177608 A1 (51) International Patent Classification: A61K31/36 (2006.01) A61P 31/10 (2006.01) A61K31/4184 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/AU2013/000487 13 May 2013 (13.05.2013) English (30) Priority Data: 2012902243 30 May 2012 (30.05.2012) English AU (71) Applicant: BIODIEM LIMITED [AU/AU]; Suite 3, Level 11, 470 Collins St., Melbourne, Victoria 3000 (AU). (72) Inventors: PHILLIPS, Julie; 11 Fifth Ave., Denistone, New South Wales 2114 (AU). SORRELL, Tania; 27 Kooyong Road, Riverview, New South Wales 2066 (AU). CHEN, Sharon; 174 Tryon Road, East Lindfield, New South Wales 2070 (AU). (74) Agent: DAVIES COLLISON CAVE; Level 15, 1 Nich olson Street, Melbourne, Victoria 3000 (AU). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) (54) Title: METHOD OF TREATING SCEDOSPORIUM SPP. INFECTION (I) 00 o l> l> i-H m i-H (57) Abstract: The present invention provides method of a treatment of Scedosporium spp. infection in an animal comprising the ® step of administering to the infected animal an effective amount of compound of formula a I or a pharmaceutically-acceptable salt CJ o & thereof
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2012902243A AU2012902243A0 (en) | 2012-05-30 | Method of treating Seedosporium spp. infection | |
PCT/AU2013/000487 WO2013177608A1 (en) | 2012-05-30 | 2013-05-13 | Method of treating scedosporium spp. infection |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201407924RA true SG11201407924RA (en) | 2014-12-30 |
Family
ID=49672167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201407924RA SG11201407924RA (en) | 2012-05-30 | 2013-05-13 | METHOD OF TREATING <i>SCEDOSPORIUM SPP</i>. INFECTION |
Country Status (10)
Country | Link |
---|---|
US (1) | US9867802B2 (en) |
EP (1) | EP2854799B1 (en) |
JP (1) | JP2015518007A (en) |
CN (1) | CN104519882A (en) |
AU (2) | AU2013204604B2 (en) |
CA (1) | CA2874881A1 (en) |
HK (1) | HK1209052A1 (en) |
SG (1) | SG11201407924RA (en) |
WO (1) | WO2013177608A1 (en) |
ZA (1) | ZA201408975B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2018310749A1 (en) * | 2017-08-01 | 2020-02-20 | Opal Biosciences Limited | Treatment of Staphylococcal and Enterococcal infections using substituted nitrostyrene compounds |
AU2021267373A1 (en) | 2020-05-06 | 2022-12-08 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors |
WO2023086319A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | 6-he tero aryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3985761A (en) * | 1974-10-24 | 1976-10-12 | Sarabhai Research Centre | Nitrothiazolyl derivatives of nitrostyrene |
JPS585902B2 (en) * | 1978-09-01 | 1983-02-02 | 株式会社大塚製薬工場 | β↓-nitrostyrene derivative |
RU2259825C9 (en) * | 2001-06-18 | 2006-04-10 | БиоДием Лимитед | Substances of antimicrobial, antifungoid and antiprotozoan activities |
JP2009512729A (en) * | 2005-10-24 | 2009-03-26 | スタヴァル ファーマ リミテッド | Methods for treating, controlling and killing fungi and bacteria |
US20080220103A1 (en) * | 2005-10-24 | 2008-09-11 | Jay Birnbaum | Method for treating/controlling/killing fungi and bacteria on living animals |
WO2008061308A1 (en) * | 2006-11-22 | 2008-05-29 | Biodiem Ltd | Protein tyrosine phosphatase modulators |
AU2009240389A1 (en) * | 2008-04-25 | 2009-10-29 | Nanobio Corporation | Nanoemulsions for treating fungal, yeast and mold infections |
UA107963C2 (en) * | 2010-06-07 | 2015-03-10 | Janssen Pharmaceutica Nv | Antifungal derivatives of 5,6-dihydro-4 - [(difluoro ethyl) phenyl] -4h-pyrrolo [1,2-a] [1,4] benzodiazepine and 4- (diftoretil) phenyl-6h-pyrolyl [1,2- a] [1,4] benzodiazepine |
-
2013
- 2013-04-12 AU AU2013204604A patent/AU2013204604B2/en not_active Ceased
- 2013-05-13 CN CN201380029050.6A patent/CN104519882A/en active Pending
- 2013-05-13 SG SG11201407924RA patent/SG11201407924RA/en unknown
- 2013-05-13 JP JP2015514283A patent/JP2015518007A/en active Pending
- 2013-05-13 AU AU2013270430A patent/AU2013270430A1/en not_active Abandoned
- 2013-05-13 CA CA2874881A patent/CA2874881A1/en not_active Abandoned
- 2013-05-13 US US14/404,851 patent/US9867802B2/en not_active Expired - Fee Related
- 2013-05-13 WO PCT/AU2013/000487 patent/WO2013177608A1/en active Application Filing
- 2013-05-13 EP EP13798071.0A patent/EP2854799B1/en not_active Not-in-force
-
2014
- 2014-12-05 ZA ZA2014/08975A patent/ZA201408975B/en unknown
-
2015
- 2015-10-08 HK HK15109813.9A patent/HK1209052A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20150126436A1 (en) | 2015-05-07 |
HK1209052A1 (en) | 2016-03-24 |
WO2013177608A1 (en) | 2013-12-05 |
AU2013204604A1 (en) | 2013-12-19 |
CA2874881A1 (en) | 2013-12-05 |
CN104519882A (en) | 2015-04-15 |
AU2013204604B2 (en) | 2016-05-19 |
EP2854799A1 (en) | 2015-04-08 |
ZA201408975B (en) | 2016-10-26 |
AU2013270430A1 (en) | 2014-12-18 |
EP2854799B1 (en) | 2018-04-25 |
EP2854799A4 (en) | 2015-10-21 |
JP2015518007A (en) | 2015-06-25 |
US9867802B2 (en) | 2018-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201901747VA (en) | Inhibitors of cellular metabolic processes | |
SG11201907034PA (en) | Methods of treating influenza | |
SG11201906386XA (en) | Combination therapy involving diaryl macrocyclic compounds | |
SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
SG11201407200TA (en) | Liquid formulation | |
SG11201408133TA (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
SG11201408094YA (en) | Neprilysin inhibitors | |
SG11201407037UA (en) | Catechol o-methyltransferase activity inhibiting compounds | |
SG11201407534PA (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
SG11201407537YA (en) | Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer | |
SG11201408261UA (en) | Syringe | |
SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
SG11201407900WA (en) | Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof | |
SG11201406787TA (en) | Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies | |
SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
SG11201407867VA (en) | Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases | |
SG11201407372UA (en) | Nampt inhibitors | |
SG11201805001UA (en) | Method of treating influenza a | |
SG11201408383SA (en) | Methods of detecting diseases or conditions using circulating diseased cells | |
SG11201407801VA (en) | Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations | |
SG11201408685WA (en) | Antibacterial microelement chelates and the use thereof in animal feeds | |
SG11201407575PA (en) | 5-amino[1,4]thiazines as bace 1 inhibitors | |
SG11201810974QA (en) | Methods and compositions for prostate cancer diagnosis and treatment | |
SG11201805263TA (en) | Compositions and methods for detecting and treating esophageal cancer | |
SG11201901689YA (en) | Compounds for treating diseases associated with a mitochondrial dysfonction |